Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Masaki Ryuzaki"'
Autor:
Chieko Itabashi, Hiroki Mizukami, Sho Osonoi, Kazuhisa Takahashi, Kazuhiro Kudo, Kanichiro Wada, Wataru Inaba, Guo Danyang, Chiaki Uchida, Satoko Umetsu, Akiko Igawa, Saori Ogasawara, Masaki Ryuzaki, Kouji Komeda, Yasuyuki Ishibashi, Soroku Yagihashi, Shigeyuki Nakaji
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/2e61f43673464d04b2870ed922b2fe98
Autor:
Chikako Fujii, Kazutoshi Miyashita, Masanori Mitsuishi, Masaaki Sato, Kentaro Fujii, Hiroyuki Inoue, Aika Hagiwara, Sho Endo, Asuka Uto, Masaki Ryuzaki, Motowo Nakajima, Tohru Tanaka, Masanori Tamaki, Ayako Muraki, Toshihide Kawai, Hiroshi Itoh
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-12 (2017)
Abstract Recently, sarcopenia has attracted attention as therapeutic target because it constitutes a risk factor for metabolic and cardiovascular diseases. We focused 5-aminolevulinic acid (ALA) which act as electron carriers in the mitochondrial ele
Externí odkaz:
https://doaj.org/article/3bbd0cbf26ea4990bafd6f92fe58cde9
Autor:
Chieko Itabashi, Hiroki Mizukami, Sho Osonoi, Kazuhisa Takahashi, Kazuhiro Kudo, Kanichiro Wada, Wataru Inaba, Guo Danyang, Chiaki Uchida, Satoko Umetsu, Akiko Igawa, Saori Ogasawara, Masaki Ryuzaki, Kouji Komeda, Yasuyuki Ishibashi, Soroku Yagihashi, Shigeyuki Nakaji
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2019)
Purpose: Small fiber dysfunction is common in subjects with diabetic polyneuropathy (DPN). It is unsettled, however, whether marginal glucose intolerance is implicated in the onset and progression of small fiber dysfunction. Herein, we explored the r
Externí odkaz:
https://doaj.org/article/3b9cc9ea4f7f463a91ecdc16b690b21c
Autor:
Masaki Ryuzaki, Hirobumi Tokuyama, Kiyotaka Uchiyama, Hideaki Nakaya, Kazuhiro Hasegawa, Kazutoshi Miyashita, Kohnosuke Konishi, Akinori Hashiguchi, Shu Wakino, Hiroshi Itoh
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 12 (2019)
Clinical application of immune checkpoint inhibitors (CPIs) including nivolumab is expanding in the field of oncology treatment. Nivolumab is an anti-programmed death 1 protein (PD-1) antibody designed to augment an immunologic reaction against cance
Externí odkaz:
https://doaj.org/article/78b013f2959541248376ef36a00a00bb
Autor:
Itaru Yasuda, Kazuhiro Hasegawa, Hirobumi Tokuyama, Naoki Washida, Keisuke Shinozuka, Marie Yasuda, Masaki Ryuzaki, Hidenori Urai, Shu Wakino, Hiroshi Itoh
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 12 (2019)
Background: Cyst infection is a complication sometimes seen in patients with autosomal dominant polycystic kidney disease (ADPKD) and often shows through a positive blood culture. However, there have been no reports of ADPKD patients whose cyst infec
Externí odkaz:
https://doaj.org/article/20a5dc0828804b4ea0301475ab5d0f60
Autor:
Masaki Ryuzaki, Asuka Uto, Hiroyuki Inoue, Hiroshi Itoh, Aika Hagiwara, Masaaki Sato, Kenichiro Kinouchi, Takuma Oshida, Kentaro Fujii, Kazutoshi Miyashita, Sho Endo
Publikováno v:
Journal of Hypertension
Background The renal tissue renin--angiotensin system is known to be activated by salt loading in salt-sensitive rats; however, the response in other organs remains unclear. Method Spontaneously hypertensive rats were subjected to normal tap water or
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2630a2d3ec4366c4bcb93d9b4485fa26
https://doi.org/10.1097/hjh.0000000000002974
https://doi.org/10.1097/hjh.0000000000002974
Autor:
Takuma Oshida, Kazutoshi Miyashita, Akiko Kubo, Masaaki Sato, Kentaro Fujii, Masaki Ryuzaki, Asuka Uto, Toshifumi Nakamura, Kenichiro Kinouchi, Sakiko Kobayashi, Hiroshi Ito
Publikováno v:
Journal of Hypertension. 41:e371
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5ef7cdb0f14b4b12dc763d7f87af9f4
https://doi.org/10.1097/01.hjh.0000916580.52112.bd
https://doi.org/10.1097/01.hjh.0000916580.52112.bd
Autor:
Erina Sugita, Homare Sonoda, Masaki Ryuzaki, Akinori Hashiguchi, Hirobumi Tokuyama, Shu Wakino, Kaori Hayashi, Takeshi Kanda, Hiroshi Itoh
Publikováno v:
Journal of Hypertension. 41:e353
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::edbcd6d9e6acf3b0b246461bab91b488
https://doi.org/10.1097/01.hjh.0000916348.77458.c1
https://doi.org/10.1097/01.hjh.0000916348.77458.c1
Autor:
Masaki Ryuzaki, Kenichiro Kinouchi, Masanori Mitsuishi, Sho Endo, Kazutoshi Miyashita, Asuka Uto, Shu Meguro, Hiroshi Itoh, Masaaki Sato
Publikováno v:
Endocrinology. 162
Glucocorticoid causes hyperglycemia, which is common in patients with or without diabetes. Prolonged hyperglycemia can be experienced even after the discontinuation of glucocorticoid use. In the present study, we examined the time course of blood glu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::326fe7ead59182f10841698e5f3c24f1
https://doi.org/10.1210/endocr/bqab193
https://doi.org/10.1210/endocr/bqab193
Autor:
Hiroshi Itoh, Shigeto Ishidoya, Itaru Yasuda, Akinori Hashiguchi, Kiyotaka Uchiyama, Ryuichi Mizuno, Marie Yasuda, Hirobumi Tokuyama, Kazuhiro Hasegawa, Masaki Ryuzaki, Shu Wakino
Publikováno v:
CEN Case Rep
Phospholipase A2 receptor (PLA2R) is the most common primary target antigen of idiopathic membranous nephropathy (MN) although PLA2R antibodies are also reported to be present in malignancy-associated MN. However, a case of PLA2R-positive MN secondar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8f3519182451340a1996bd7bd88a42
https://europepmc.org/articles/PMC8019443/
https://europepmc.org/articles/PMC8019443/
